Coherus BioSciences Inc (CHRS)
0.714
+0.04
(+6.57%)
USD |
NASDAQ |
Nov 05, 10:17
Coherus BioSciences Shareholders Equity (Quarterly): -84.11M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -84.11M |
| March 31, 2024 | -81.84M |
| December 31, 2023 | -193.42M |
| September 30, 2023 | -133.60M |
| June 30, 2023 | -174.76M |
| March 31, 2023 | -196.51M |
| December 31, 2022 | -137.42M |
| September 30, 2022 | -97.13M |
| June 30, 2022 | -22.63M |
| March 31, 2022 | 12.56M |
| December 31, 2021 | 97.73M |
| September 30, 2021 | 130.76M |
| June 30, 2021 | 156.22M |
| March 31, 2021 | 127.67M |
| December 31, 2020 | 280.97M |
| September 30, 2020 | 255.73M |
| June 30, 2020 | 213.38M |
| March 31, 2020 | 157.28M |
| December 31, 2019 | 105.21M |
| September 30, 2019 | 56.02M |
| June 30, 2019 | -3.985M |
| Date | Value |
|---|---|
| March 31, 2019 | -38.52M |
| December 31, 2018 | -38.59M |
| September 30, 2018 | 12.39M |
| June 30, 2018 | 63.17M |
| March 31, 2018 | -1.794M |
| December 31, 2017 | 31.82M |
| September 30, 2017 | 56.20M |
| June 30, 2017 | 32.14M |
| March 31, 2017 | 78.18M |
| December 31, 2016 | 20.53M |
| September 30, 2016 | 32.87M |
| June 30, 2016 | -60.89M |
| March 31, 2016 | -66.01M |
| December 31, 2015 | -6.207M |
| September 30, 2015 | 40.57M |
| June 30, 2015 | 96.75M |
| March 31, 2015 | 38.15M |
| December 31, 2014 | 66.80M |
| September 30, 2014 | 9.334M |
| June 30, 2014 | 14.69M |
| December 31, 2013 | -42.38M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-196.51M
Minimum
Mar 2023
280.97M
Maximum
Dec 2020
21.90M
Average
12.56M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Repligen Corp | 1.986B |
| Evoke Pharma Inc | 2.665M |
| Personalis Inc | 112.27M |
| Maravai LifeSciences Holdings Inc | 436.93M |
| Tempus AI Inc | 98.25M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 674.86M |
| Total Liabilities (Quarterly) | 758.96M |
| Debt to Equity Ratio | -3.14 |
| Current Ratio | 1.205 |
| Net Debt Paydown Yield | 20.83% |